- |||||||||| Trial completion, Phase classification, Trial completion date, Trial primary completion date: ASVF-2016: Point-of-Care Adipose-derived Cells for Hair Growth (clinicaltrials.gov) - Feb 22, 2019
P=N/A, N=9, Completed, N=20 --> 5 | Recruiting --> Terminated | Trial primary completion date: Sep 2018 --> Feb 2019; Poor recruitment and follow up Active, not recruiting --> Completed | Phase classification: P1 --> PN/A | Trial completion date: Jul 2019 --> Jan 2019 | Trial primary completion date: Jul 2019 --> Jan 2019
- |||||||||| tofacitinib / Generic mfg.
Trial completion: Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants (clinicaltrials.gov) - Jan 30, 2019 P2, N=10, Completed, Active, not recruiting --> Completed | Phase classification: P1 --> PN/A | Trial completion date: Jul 2019 --> Jan 2019 | Trial primary completion date: Jul 2019 --> Jan 2019 Active, not recruiting --> Completed
- |||||||||| minoxidil / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Minoxidil Response Testing in Males With Androgenetic Alopecia (clinicaltrials.gov) - Oct 5, 2018 P=N/A, N=300, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Oct 2018 | Trial primary completion date: Dec 2017 --> Oct 2018
- |||||||||| Enrollment closed: ASVF-2016: Point-of-Care Adipose-derived Cells for Hair Growth (clinicaltrials.gov) - Sep 27, 2018
P1, N=12, Active, not recruiting, Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Oct 2018 | Trial primary completion date: Dec 2017 --> Oct 2018 Recruiting --> Active, not recruiting
- |||||||||| Trial completion, Trial initiation date, Trial primary completion date: VOLUME2: A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2) (clinicaltrials.gov) - Sep 4, 2018
P=N/A, N=19, Completed, Active, not recruiting --> Completed | Initiation date: Jan 2016 --> Jul 2016 | Trial primary completion date: Dec 2016 --> Jun 2017 Active, not recruiting --> Completed | Initiation date: Jul 2016 --> Jan 2016 | Trial primary completion date: Aug 2017 --> Dec 2016
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Topical Garlic Concentrate for Alopecia Areata in Children (clinicaltrials.gov) - Apr 19, 2018
P3, N=8, Terminated, Active, not recruiting --> Completed N=20 --> 8 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Aug 2017; Lack of efficacy of the study medication
- |||||||||| Trial completion date, Trial primary completion date: ASVF-2016: Point-of-Care Adipose-derived Cells for Hair Growth (clinicaltrials.gov) - Apr 11, 2018
P1, N=8, Recruiting, N=20 --> 8 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Aug 2017; Lack of efficacy of the study medication Trial completion date: Jul 2018 --> Jul 2019 | Trial primary completion date: Jul 2018 --> Jul 2019
- |||||||||| minoxidil / Generic mfg.
Trial primary completion date: Minoxidil Response Testing in Females With Female Pattern Hair Loss (clinicaltrials.gov) - Jan 10, 2018 P=N/A, N=300, Active, not recruiting, Not yet recruiting --> Completed | N=88 --> 22 | Initiation date: Sep 2016 --> Jun 2017 | Trial primary completion date: Sep 2018 --> Aug 2017 Trial primary completion date: Dec 2017 --> Dec 2018
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss (clinicaltrials.gov) - Jul 18, 2017
P2, N=33, Completed, Trial primary completion date: Jan 2018 --> Jun 2018 Active, not recruiting --> Completed | N=90 --> 33 | Trial primary completion date: Feb 2016 --> Feb 2015
- |||||||||| prednisone / Generic mfg.
Trial primary completion date: The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade (clinicaltrials.gov) - Jun 14, 2017 P3, N=90, Recruiting, Active, not recruiting --> Completed | N=90 --> 33 | Trial primary completion date: Feb 2016 --> Feb 2015 Trial primary completion date: Feb 2017 --> Dec 2017
- |||||||||| Trial completion, Trial primary completion date: A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp (clinicaltrials.gov) - May 5, 2017
P3, N=492, Completed, Trial primary completion date: Feb 2017 --> Dec 2017 Active, not recruiting --> Completed | Trial primary completion date: May 2016 --> Aug 2016
- |||||||||| Trial completion, Stroma: Adipose-derived SVF for Treatment of Alopecia (clinicaltrials.gov) - May 1, 2017
P=N/A, N=8, Completed, Active, not recruiting --> Completed | Trial primary completion date: May 2016 --> Aug 2016 Active, not recruiting --> Completed
- |||||||||| Lumigan (bimatoprost) / Senju, AbbVie
Enrollment change, Trial termination, Trial primary completion date: Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) (clinicaltrials.gov) - Mar 17, 2017 P1, N=53, Terminated, Recruiting --> Active, not recruiting N=90 --> 53 | Recruiting --> Terminated | Trial primary completion date: Oct 2017 --> Jan 2017
- |||||||||| Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Trial completion, Trial initiation date, Trial primary completion date: Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin (clinicaltrials.gov) - Mar 3, 2017 P=N/A, N=20, Completed, Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Mar 2009 Not yet recruiting --> Completed | Initiation date: Dec 2010 --> Oct 2007 | Trial primary completion date: Dec 2011 --> Oct 2009
- |||||||||| minoxidil / Generic mfg.
Trial primary completion date: Minoxidil Response Testing in Females With Female Pattern Hair Loss (clinicaltrials.gov) - Jan 24, 2017 P=N/A, N=300, Active, not recruiting, Active, not recruiting --> Completed | N=250 --> 399 | Trial primary completion date: Jan 2015 --> Jul 2016 Trial primary completion date: Dec 2016 --> Dec 2017
- |||||||||| calcitriol (BPM 31543) / Berg
Enrollment closed, Enrollment change, Trial primary completion date, Metastases: Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease (clinicaltrials.gov) - Dec 22, 2016 P1, N=30, Active, not recruiting, N=10 --> 4 | Recruiting --> Terminated; low enrollment Recruiting --> Active, not recruiting | N=18 --> 30 | Trial primary completion date: Aug 2016 --> Jan 2017
|